News

AstraZeneca stated that the review by the advisory committee, part of the FDA’s evaluation of the new drug application (NDA) submitted for Ticagrelor, is based on the results

Bruker has posted a net income of $22.6m for the second quarter 2010, or $0.14 per diluted share, compared to net income of $12.9, or $0.08 per diluted

Under the terms of merger agreement, diaDexus expects to operate as a wholly-owned subsidiary of VaxGen. VaxGen has issued approximately 19,960,534 shares to certain diaDexus stockholders and officers,

Amarantus claimed that MANF is a highly potent, neurotrophic factor currently in pre-clinical development for the treatment of a range of diseases that includes Parkinson’s disease. Amarantus said

Quick-Med’s patented technology, Nimbus is a antimicrobial technology that has been custom designed for wound care and other medical applications. Nimbus received de Novo FDA clearance in 2009

Caraco Pharma earned net income of $1.2m during the first quarter of Fiscal 2011, as compared to incurring a net loss of $9.4m during the corresponding period of

Mylan said that this new plan will generate 400 jobs in the northwest of the country, Mylan has stated that it has purchased a big hall of around

The kit combines Gentel’s APiX chromogenic detection platform and Clontech’s research-validated Antibody 380 array technology to help scientists study tumor-associated antigens, compare proteomic and transcriptomic data, and perform

The Chinese Letters Patent No 1758920 covers pharmaceutical compositions that comprise the greater and superior dosage size of chondroitin sulfate, and the use of those compositions for the